Abstract
Current Medicinal Chemistry - Central Nervous System Agents
Title: Subject Index to Volume 3
Volume: 4 Issue: 1
Author(s): Bentham Science Publishers
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Subject Index to Volume 3, Current Medicinal Chemistry - Central Nervous System Agents 2004; 4 (1) . https://dx.doi.org/10.2174/1568015043477612
DOI https://dx.doi.org/10.2174/1568015043477612 |
Print ISSN 1568-0150 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6158 |
10
Related Articles
-
Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment
CNS & Neurological Disorders - Drug Targets Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges
Current Neuropharmacology New Ways of Detecting ADRs in Neonates and Children
Current Pharmaceutical Design Cough Recording Technology
Current Respiratory Medicine Reviews Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
Current Gene Therapy Off-Label Trazodone Prescription: Evidence, Benefits and Risks
Current Pharmaceutical Design GPCR Heteromers and their Allosteric Receptor-Receptor Interactions
Current Medicinal Chemistry Magnetic Resonance Imaging of Iron in Parkinsons Disease
Current Medical Imaging <i>Withania somnifera</i> in Neurological Disorders: Ethnopharmacological Evidence, Mechanism of Action and its Progress in Delivery Systems
Current Drug Metabolism New Therapeutic Strategy for Parkinson’s and Alzheimer’s Disease
Current Medicinal Chemistry Protein Interaction Studies for Understanding the Tremor Pathway in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Halogen Dance Reaction and its Application in Organic Synthesis
Current Organic Chemistry Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist
Current Neuropharmacology Drug Therapy in Schizophrenia
Current Pharmaceutical Design Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants
Current Pharmaceutical Design Neuroprotective Strategies for Neurological Disorders by Natural Products: An update
Current Neuropharmacology Current Strategies for the Development of Novel Antipsychotic Drugs
Mini-Reviews in Medicinal Chemistry Histone Post-translational Modifications in Huntington’s and Parkinson’s Diseases
Current Pharmaceutical Design Freezing of Gait in Parkinsonism and its Potential Drug Treatment
Current Neuropharmacology Gene-Gene Interactions in a Context of Individual Variability in Antipsychotic Drug Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine